Custom Search
News
Thursday 05 April 2007
Marketing authorisation from the Netherlands for Lisinopril.
The stock price of the Aurobindo Pharma closed at 694.55, up 3.56 per cent compared with its Tuesday close. The stock opened at Rs 684 and touched its intraday high of Rs 701 supported by heavy
The stock price of the Aurobindo Pharma closed at 694.55, up 3.56 per cent compared with its Tuesday close. The stock opened at Rs 684 and touched its intraday high of Rs 701 supported by heavy volumes of 34,713 shares.
According to its announcements to BSE, the company has received the marketing authorisation from Medicines Evaluation Board (MEB), the Netherlands for Lisinopril 10, 20, 30 and 40 mg tablets.
This, the company expects to help in obtaining similar marketing authorisation for Lisinopril tablets in the other countries of the European Union.